
The Safety Signal: AI in Pharmacovigilance
AI helps drug safety teams detect adverse-event signals across reports, literature, clinical data, and real-world evidence.
Read MoreZharfAI Team

The promise of imaging AI is not only better detection. In overloaded health systems, the operational question is which study needs attention first and what evidence should be surfaced to the clinician.
In 2026, the practical question is no longer whether AI can produce a fluent answer. The question is whether the system can connect to trustworthy context, act within a narrow boundary, and leave enough evidence for people to review the result.
AI can check image quality, flag urgent findings, compare prior studies, prepare structured summaries, and reduce time spent searching through records.
Start with one narrow workflow and define what the AI is allowed to read, recommend, and change. Add evaluation examples from real edge cases, not only happy-path demos. Keep logs for prompts, retrieved context, tool calls, approvals, and final outcomes. Give users a visible way to correct the system when it is wrong.
Clinical systems require validation, documentation, and clear responsibility. AI should support the clinician, not create an invisible second diagnosis pathway.
At ZharfAI, we see the strongest AI projects as operating systems for better decisions. The model matters, but the surrounding product discipline matters just as much: clean data, permissions, evaluations, human review, and a feedback loop that improves after every deployment.

AI helps drug safety teams detect adverse-event signals across reports, literature, clinical data, and real-world evidence.
Read More
AI-powered hospital command centers coordinate beds, staff, equipment, transfers, and risk signals in real time.
Read More
Sovereign AI is about control over data, compute, models, talent, standards, and deployment choices, not just where a model is hosted.
Read MoreGet in touch with our team to discuss how we can help your business.